* Industry diversification based on Moody's industry classification. Measured as the fair value of investments for each category against the total fair value of all investments. Totals may not sum due to rounding.
A balanced portfolio built on the cornerstones of diversification and selectivity
Anchored in senior secured loans, NCDL has built a scaled and diversified portfolio by industry, investment type and portfolio company. Selectivity, diversification and rigorous underwriting are key to our investment philosophy, enabling strong credit performance since inception.
Portfolio holdings
Top ten positions
Represents the top ten positions in NCDL based on Fair Value as of September 30, 2025
| Company | Fair value ($ in thousands) | Industry | Asset Types | Pricing1 |
|---|---|---|---|---|
| Heartland Home Services, Inc. (Helios Buyer, Inc.) | 5,390,240 | Capital Equipment | First Lien Debt (Delayed Draw) | S + 6.00% |
| Heartland Home Services, Inc. (Helios Buyer, Inc.) | 2,471,582 | Capital Equipment | First Lien Debt (Delayed Draw) | S + 6.00% |
| Heartland Home Services, Inc. (Helios Buyer, Inc.) | 6,215,381 | Capital Equipment | First Lien Debt | S + 6.00% |
| Healthspan Buyer, LLC (Thorne HealthTech) | 10,394,193 | Healthcare & Pharmaceuticals | First Lien Debt | S + 4.75% |
| Health Management Associates, Inc. | 1,062,641 | Healthcare & Pharmaceuticals | First Lien Debt (Delayed Draw) | S + 6.25% |
| Health Management Associates, Inc. | 8,213,684 | Healthcare & Pharmaceuticals | First Lien Debt | S + 6.25% |
| HMN Acquirer Corp. | 6,473,505 | Healthcare & Pharmaceuticals | First Lien Debt | S + 4.50% |
| HMN Acquirer Corp. | (21,588) | Healthcare & Pharmaceuticals | First Lien Debt (Delayed Draw) | S + 4.50% |
| HMA Equity, LP (Health Management Associates) | 405,902 | Healthcare & Pharmaceuticals | Class A Common Units | |
| HBB Parent, LLC (High Bar Brands) | 323,604 | Automotive | Class A Units | |
| GreyLion TGNL Holdings | 853,752 | Construction & Building | Limited Partnership Interests | |
| Genesee Scientific LLC | 5,335,657 | Healthcare & Pharmaceuticals | First Lien Debt | S + 5.75% |
| Genesee Scientific LLC | 1,397,020 | Healthcare & Pharmaceuticals | First Lien Debt (Delayed Draw) | S + 5.75% |
| Geds Equity Investors, LP (Esquire Deposition Services) | 270,737 | Services: Business | Class A Limited Partnership Units | |
| Gannett Fleming, Inc. | (14,280) | Construction & Building | Revolving Loan | S + 4.75% |
| Gannett Fleming, Inc. | 17,527,751 | Construction & Building | First Lien Debt | S + 4.75% |
| Gabriel Partners, LLC | 668,568 | Services: Business | First Lien Debt | 5.77% (Cash) 5.45 (PIK) |
| Gabriel Partners, LLC | 3,783,145 | Services: Business | First Lien Debt | 5.77% (Cash) 5.45 (PIK) |
| Gabriel Partners, LLC | 9,163,732 | Services: Business | First Lien Debt | 5.77% (Cash) 5.45 (PIK) |
| Gabriel Partners, LLC | 1,526,674 | Services: Business | First Lien Debt (Delayed Draw) | 5.77% (Cash) 5.45 (PIK) |
| GNX HBS PARENT, LLC | 2,508,019 | High Tech Industries | First Lien Debt | S + 4.75% |
| GNX HBS PARENT, LLC | (6,176) | High Tech Industries | First Lien Debt (Delayed Draw) | S + 4.75% |
| GNX HBS Holdings, LLC | 59,677 | High Tech Industries | Class A Units | |
| GHR Healthcare, LLC | 5,959,810 | Healthcare & Pharmaceuticals | First Lien Debt | S + 5.25% |
| GHR Healthcare, LLC | 3,520,674 | Healthcare & Pharmaceuticals | First Lien Debt | S + 5.25% |
| GHR Healthcare, LLC | 7,572,004 | Healthcare & Pharmaceuticals | First Lien Debt | S + 5.25% |
| GHR Healthcare, LLC | 1,864,267 | Healthcare & Pharmaceuticals | First Lien Debt (Delayed Draw) | S + 5.25% |
| GHR Healthcare, LLC | 4,640,015 | Healthcare & Pharmaceuticals | First Lien Debt | S + 5.25% |
| Force Electrical Buyerco, LLC | 36,814 | Utilities: Electric | First Lien Debt | S + 4.50% |
| Force Electrical Buyerco, LLC | 399 | Utilities: Electric | First Lien Debt (Delayed Draw) | S + 4.50% |
1. The majority of the investments bear interest at rates that may be determined by reference to Secured Overnight Financing Rate ("SOFR" or "S"), which reset monthly or quarterly. For each such investment, the Company has provided the spread over SOFR and the current contractual interest rate in effect at December 31, 2025. As of December 31, 2025, rates for 1M S, 3M S, 6M S, 12M S ("SOFR") are 3.69%, 3.65%, 3.57%, and 3.42% respectively. Certain investments are subject to a SOFR floor or may utilize an alternative reference rate such as U.S. Prime Rate (“P”). For fixed rate loans, a spread above a reference rate is not applicable.